Previous
Next

Country/Region

May 09, 2015

After 42 days with no recorded cases of Ebola, Liberia has been declared Ebola-free by the World Health Organization (WHO) – news that has been welcomed by the international medical organization Médecins Sans Frontières/Doctors Without Borders (MSF).

April 02, 2015

Routine vaccination activities in West African countries affected by the Ebola crisis have been significantly reduced since the Ebola outbreak began. In Montserrado County, Liberia, Médecins Sans Frontières/Doctors Without Borders (MSF) recently conducted a measles vaccination campaign with adapted safety protocols.

Philippe Le Vaillant, MSF’s representative in Liberia, talks about the need to increase vaccination coverage while rebuilding confidence in medical services.

February 03, 2015

A trial of the experimental Ebola drug brincidofovir in Liberia has been halted due to a significant drop in the number of new Ebola cases, coupled with the January 30 announcement by the drug’s manufacturer that it would no longer participate in the trial.

Led by Oxford University, the trial into a potential treatment for the disease was launched in early January in an Ebola management centre run by international medical organization Médecins Sans Frontières/Doctors Without Borders (MSF) in the Liberian capital Monrovia.  

January 26, 2015

A downward trend of new cases has been reported at Médecins Sans Frontières/Doctors Without Borders (MSF) Ebola management centres across Guinea, Liberia and Sierra Leone, with just over 50 patients currently in eight centres. While this is a promising development, the medical humanitarian organization cautions that loss of vigilance now would jeopardize the progress made in stemming the epidemic.

January 08, 2015

A clinical trial of a possible treatment for Ebola began on January 1 at ELWA 3, the Ebola Management Centre run by Médecins Sans Frontières/Doctors Without Borders (MSF) in Monrovia, the capital of Liberia.

December 12, 2014

The Ebola situation has improved in Liberia’s Lofa County, and Médecins Sans Frontières/Doctors Without Borders (MSF) has decided to withdraw from the area. New actors have arrived to help, and since October 30 there have been no more Ebola patients in the Ebola Management Centre (EMC) in Foya. The success of MSF’s intervention in northern Liberia can be considered a model of response, benefitting from a comprehensive approach and constant community involvement.

October 17, 2014

Dr. Bertrand Draguez is a medical director with Médecins Sans Frontières/Doctors Without Borders (MSF) currently working on the West Africa Ebola outbreak. Here he explains why developing vaccines and treatments for Ebola is important, what is needed in order for them to make an impact in this outbreak, and why MSF is taking exceptional measures in facilitating clinical trials for potential treatments.

September 15, 2014

By Martin Zinggl

In the ‘Ebola-confirmed’ area of the Médecins Sans Frontières/Doctors Without Borders (MSF) Case Management Centre (CMC) in Foya, Liberia, roughly two thirds of patients don’t survive the Ebola virus. The patients gather on wooden benches and plastic chairs. Out of a transistor radio plays loud Azonto, music originating from Ghana. People are weak, lying in their beds while their immune systems are trying to fight the deadly invader in their bodies.

September 11, 2014

Pierre Trbovic, an anthropologist from Belgium, arrived in the Liberian capital city Monrovia in late August to help with MSF’s response to the Ebola epidemic. Finding the treatment centre full, health staff overwhelmed and sick people queuing in the street, Pierre volunteered for the heartwrenching job of turning people away.
 

By Pierre Trbovic

August 08, 2014

Dr. Armand Sprecher is a doctor with  Médecins Sans Frontières/Doctors Without Borders (MSF), who specializes in hemorrhagic fevers. In the interview below he responds to questions about the treatment available for Ebola, and whether experimental drugs can form part of MSF's response to the disease outbreak currently affecting West Africa.

 

Pages